| Literature DB >> 23583476 |
Chiara Fuccio1, Elena Giulia Spinapolice, Alice Ferretti, Paolo Castellucci, Maria Cristina Marzola, Giuseppe Trifirò, Domenico Rubello.
Abstract
It is well known the useful role of ¹⁸F-FDG-PET/CT for differential diagnosis between benign and malignant disease, for staging, for monitoring response and for prognosis regarding mesothelioma. Recently, literature was enriched with new interesting studies regarding the potential applications of ¹⁸F-FDG-PET/CT in this field. The purpose of this review is to evaluate articles published on line (PubMed) from January 2011 until October 2012 in order to obtain an overview of recent progress of molecular imaging in malignant mesothelioma. The main topics concern the use of ¹⁸F-FDG-PET/CT in radiation therapy planning, monitoring of treatment (surgery/chemotherapy) response and prognosis assessment.Entities:
Keywords: (18)F-FDG-PET/CT; Malignant mesothelioma; Prognosis; Radiation therapy planning; Treatment response
Mesh：
Substances：
Year: 2013 PMID： 23583476 DOI： 10.1016/j.biopha.2013.01.008
Source DB: PubMed Journal: Biomed Pharmacother ISSN： 0753-3322 Impact factor: 6.529